1Stuehr D J. Structure-function aspects in the nitric ox ide synthases. Annu Rev Pharmacol Toxical, 1997, 37: 339-359.
2Sase K, Michel T. Expression and regulation of endothelial nitric oxide synthase. Trends Cardiovasc Med, 1997, 7: 25-34.
3Venema V J, Marrero M B, Venema R C. Bradykinin stimulated protein tyrosine phosphorylation promotes endothelial nitric oxide synthase translation to the cy toskeleton. Biochem Biophys Res Commun, 1996, 226 (3) :703-710.
4Kroncke K D, Fehsel K, Kolb-Bachofen V. Nitric ox ide: Cytotoxity versus cytoprotection, how, why, when, where? NO Biol Chem, 1997, 1:107-120.
5Laufs U, La Fata V, Plutzky J, et al. Upregulation of endothelial nitric oxide synthase by HMGCoA reductase inhibitors. Circulation, 1998,97(12): 1129-1135.
6Wilcox J N, Subramanian R R, Sundell C, et al. Ex pression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Bio1,1997,17(11) :2479-2488.
7Beckman J S, Koppend W H. Nitric oxide, superoxide and peroxynitrite: The good, the bad and the ugly. Am J Physiol,1996,271(5 part 1) :C1424-C1437.
8Miles A M, Bohle D S, Glassbrennor P A, et al. Mod ulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J Biol Chem, 1996, 271 (1) :40-47.
9Lefer D J, Scalia R, Campbell B, et al. Peroxynitrite inhibits leukocyte-endothelial cell interactions and pro tects against isehemia-reperfusion injury in rats. J Clin Invest,1997, 99(4) :684-691.
10Leeuwenburgh C, Hardy M M, Hazan S L, et al. Re active nitrogen intermediates promote low density lipo protein oxidation in human atherosclerotic intima. J Biol Chem,1997, 272(3) :1433-1436.
